Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of FGFR1

被引:1
|
作者
Kobayashi, Sachiko [1 ,2 ]
Tanigawa, Junpei [3 ]
Kondo, Hidehito [3 ,4 ]
Nabatame, Shin [3 ]
Maruoka, Azusa [2 ]
Sho, Hiroyuki [2 ]
Tanikawa, Kazuko [2 ]
Inui, Ryoko [2 ]
Otsuki, Michio [1 ]
Shimomura, Iichiro [1 ]
Ozono, Keiichi [3 ]
Hashimoto, Kunihiko [2 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Daini Osaka Police Hosp, Dept Internal Med, Div Diabet & Endocrinol, 2-6-40 Karasugatsuji, Tennoji, Osaka 5438922, Japan
[3] Osaka Univ, Grad Sch Med, Dept Pediat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[4] Kyoto Daiichi Red Cross Hosp, Dept Pediat, Higashiyama Ku, 15-749 Honmachi, Kyoto 6050981, Japan
关键词
FGFR1; mutation; hypernatremia; hypogonadotropic hypogonadism; PITUITARY-GONADAL RELATIONS; ADIPSIC HYPERNATREMIA; DIABETES-INSIPIDUS; INFANCY;
D O I
10.1210/jendso/bvaa041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hartsfield syndrome (HS: OMIM 615465) is a rare congenital disease associated with a mutation of the fibroblast growth factor receptor 1 gene (FGFR1) with the main features of holoprosencephaly and ectrodactyly. Patients with HS also present with endocrinological deficits, such as isolated hypogonadotropic hypogonadism and central diabetes insipidus. Although there are several studies on infancy/childhood history, there is no study of infant/childhood/adolescent/young adult HS natural history and endocrinological findings. Here, we report a male patient with HS associated with a novel de novo FGFR1 mutation (c. 1868A> C). The endocrinological profile was evaluated at ages 1 and 31 years. This long-term follow-up study highlights functional changes in the posterior pituitary gland and features of bone metabolism disorder. We also describe the anterior pituitary function. To our knowledge this is the first description of the natural history of an HS patient through birth to young adult age. Although the HS infants reported in the literature develop central diabetes insipidus, little is known about the serial changes in pituitary gland function during growth in HS patients. In this study we describe an adult patient with HS who showed improvement of hypernatremia during early adulthood. In addition, we emphasize the importance of prevention and treatment of osteoporosis in HS. (C) Endocrine Society 2020.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Actionable FGFR1 and BRAF mutations in adult circumscribed gliomas
    Elena Trisolini
    Dounia El Wardighi
    Marine Giry
    Priscilla Bernardi
    Renzo Luciano Boldorini
    Karima Mokhtari
    Marc Sanson
    Journal of Neuro-Oncology, 2019, 145 : 241 - 245
  • [42] Variable Expressivity of Pfeiffer Syndrome in a Family With FGFR1 p.Pro252Arg Mutation
    Bessenyei, Beata
    Tihanyi, Mariann
    Hartwig, Marianna
    Szakszon, Katalin
    Olah, Eva
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (12) : 3176 - 3179
  • [43] Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification
    Cheng, Fiona Tsui-Fen
    Fu Ou-Yang
    Lapke, Nina
    Tung, Kai-Che
    Chen, Yen-Kung
    Chou, Yuh-Yu
    Chen, Shu-Jen
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (12): : 1456 - 1459
  • [44] Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation
    Sievers, Philipp
    Schrimpf, Daniel
    Stichel, Damian
    Reuss, David E.
    Hasselblatt, Martin
    Hagel, Christian
    Staszewski, Ori
    Hench, Juergen
    Frank, Stephan
    Brandner, Sebastian
    Korshunov, Andrey
    Wick, Wolfgang
    Pfister, Stefan M.
    Reifenberger, Guido
    von Deimling, Andreas
    Sahm, Felix
    Jones, David T. W.
    ACTA NEUROPATHOLOGICA, 2020, 139 (02) : 403 - 406
  • [45] Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutation
    Philipp Sievers
    Daniel Schrimpf
    Damian Stichel
    David E. Reuss
    Martin Hasselblatt
    Christian Hagel
    Ori Staszewski
    Jürgen Hench
    Stephan Frank
    Sebastian Brandner
    Andrey Korshunov
    Wolfgang Wick
    Stefan M. Pfister
    Guido Reifenberger
    Andreas von Deimling
    Felix Sahm
    David T. W. Jones
    Acta Neuropathologica, 2020, 139 : 403 - 406
  • [46] Identification of a novel gene, FGFR1OP2, fused to FGFR1 in 8p11 myeloproliferative syndrome
    Grand, EK
    Grand, FH
    Chase, AJ
    Ross, FM
    Corcoran, MM
    Oscier, DG
    Cross, NCP
    GENES CHROMOSOMES & CANCER, 2004, 40 (01): : 78 - 83
  • [47] Ameloblastic Fibro-Odontoma with an FGFR1 Mutation: A Case Report
    Aouam, Oumaima
    Janssen, Nard G.
    de Leng, Wendy W. J.
    Breimer, Gerben E.
    HEAD & NECK PATHOLOGY, 2025, 19 (01):
  • [48] Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients
    Ishi, Yukitomo
    Yamaguchi, Shigeru
    Hatanaka, Kanako C.
    Okamoto, Michinari
    Motegi, Hiroaki
    Kobayashi, Hiroyuki
    Terasaka, Shunsuke
    Houkin, Kiyohiro
    JOURNAL OF NEUROSURGERY, 2021, 134 (03) : 733 - 741
  • [49] Dental agenesis in Kallmann syndrome individuals with FGFR1 mutations
    Bailleul-Forestier, Isabelle
    Gros, Catherine
    Zenaty, Delphine
    Bennaceur, Selim
    Leger, Juliane
    de Roux, Nicolas
    INTERNATIONAL JOURNAL OF PAEDIATRIC DENTISTRY, 2010, 20 (04) : 305 - 312
  • [50] New intronic Fibroblast Growth Factor Receptor 1 (FGFR1) mutation leading to disrupted splicing and Kallmann syndrome
    Kansakoski, J.
    Vaaralahti, K.
    Raivio, T.
    HUMAN REPRODUCTION, 2018, 33 (02) : 328 - 330